NVUS Stock Predictions
| Recent NVUS Stock Price | NVUS Stock Predictions | |
| $0.00 |  NA% |
$0.00 |
| Recent NVUS Analyst Ratings Breakdown, Making NVUS Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | ||||
| Buy ratings: | ||||
| Hold ratings: | ||||
| Sell ratings: | ||||
| Strong sell ratings: | ||||
| Average rating: | ||||
For the NVUS stock predictions from the analysts covering Eledon Pharmaceuticals Inc, we have collected all of the individual NVUS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the different analysts covering NVUS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NVUS stock predictions may vary widely, another useful metric to consider is the median NVUS stock prediction, which represents the price at which half of the analysts
made NVUS stock predictions that were higher and half made NVUS stock predictions that were lower. This makes for a different take on the NVUS stock predictions out there, as compared to average or mean.
And that median across all the individual NVUS stock predictions was: $ as of .
The very highest of the NVUS stock predictions for one year price target was $, while the very lowest of the NVUS stock predictions in the analyst group was
$ (with a standard deviation of $). Get the latest Zacks research report on NVUS — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• ONEM Stock Predictions
• EIGI Stock Predictions
• LKQ Stock Predictions
• NTGR Stock Predictions
• AERI Stock Predictions
• CSBR Stock Predictions
• EWBC Stock Predictions
• NKTR Stock Predictions
• ATEC Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free NVUS Email Alerts:
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
